Noone has tested single-dose. In this case it may sound like too much nitpicking, but the general principle is that you don't roll out something you haven't te

Noone has tested single-dose. In this case it may sound like too much nitpicking, but the general principle is that you don't roll out something you haven't tested in a trial. In general this is a good principle. I hope they'll do trials comparing single to double-dose soon.